Lonza Announces Second Global Endotoxin Testing Summit – and Another Opportunity to “Flip” Crabs

Walkersville, MD (USA), 2 December 2015 – Lonza will host its next Global Endotoxin Testing Summit on 23-25 May 2016 in Annapolis, MD (USA) and Pickering Beach, DE (USA). Organized by one of the world’s leading suppliers of endotoxin detection products, this second conference will build on the success of the inaugural Global Endotoxin Testing Summit held in June 2015. 

 

Keeping with the format of the first meeting, the 2016 summit will feature a respected and diverse panel of speakers comprising end-users, vendors and regulatory representatives, who will discuss significant issues affecting the endotoxin detection community. Topics will include low endotoxin recovery (LER), regulatory guidance updates, alternative methods like the monocyte activation test (MAT) and recombinant Factor C and other concerns. It will also include another visit to the Horseshoe Crab Sanctuary Beach.

 

“We received great feedback from attendees of the summit last spring, not just about the relevance of the topics discussed, but also about the horseshoe crab experience and the relaxed atmosphere of the meeting,” said Katrin Hoeck, Lonza’s Head of Marketing for Analysis & Testing. “This reinforced our belief that the summit should continue to serve the community by bridging the gap between end-users, vendors and regulatory personnel. We’re looking forward to next year’s event and would encourage interested parties to register early to ensure they secure their space.” 

 

One of the more unusual features of the Global Endotoxin Testing Summit is the opportunity for attendees to explore the natural habitat of the Atlantic horseshoe crab – one of four species of horseshoe crab so critical to this industry. Previous summit attendees visited a Horseshoe Crab Sanctuary Beach during the peak of spawning season to save and “flip” crabs that were stranded on shore as part of a collaboration with the Ecological Research and Development Group (ERDG) and its Just Flip ’em!® program. 

 

Glenn Gauvry, founder of ERDG, shared his excitement and appreciation at having such a large group come out to learn more about horseshoe crabs: “The community here in Pickering Beach really welcomes the sight of so many individuals coming out to help preserve the ecological jewel in our backyards. People were spread out over the entire beach from north to south, and no stranded horseshoe crabs were left unattended.”

 

For more information about Lonza’s Second Global Endotoxin Testing Summit, visit www.lonza.com/endosummit. 

 

About Lonza 

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. 

 

Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

 

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.

 

Lonza Contact Information

 

Lonza Cologne GmbH - Manager Marketing Communications

Petra Haberkamm

Tel +49 221 991990

Fax +49 221 99199498

marcom.lbs@lonza.com 

 

Lonza Group Ltd - Head Corporate Communications

Dominik Werner

Tel +41 61 316 8798

Fax +41 61 316 9540

dominik.werner@lonza.com 

 

Lonza Group Ltd - Head External Communications

Constance Ward

Tel +41 61 316 8840 

Fax +41 61 316 9840

constance.ward@lonza.com 

 

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

 

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.